🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, risking fines, prosecution or prison.

Platform Response and Content Elimination

Based on the social media company, the platform has removed violative material and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

After moments of entering one group, a vendor shared contact information, where most transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts display dark colored parcels with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious medical dangers”.